Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
27.82
+0.15 (0.54%)
Feb 10, 2026, 10:43 AM EST - Market open

Roivant Sciences Revenue

Roivant Sciences had revenue of $2.00M in the quarter ending December 31, 2025, a decrease of -77.83%. This brings the company's revenue in the last twelve months to $13.31M, down -56.36% year-over-year. In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%.

Revenue (ttm)
$13.31M
Revenue Growth
-56.36%
P/S Ratio
1,487.86
Revenue / Employee
$17,747
Employees
750
Market Cap
19.91B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M1.18M3.75%
Mar 31, 202331.53M-23.76M-42.97%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 202067.69M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte4.81B
Genmab3.85B
BioNTech SE3.70B
Royalty Pharma2.35B
Exelixis2.29B
Moderna2.23B
Ionis Pharmaceuticals966.96M
Ascendis Pharma758.59M
Revenue Rankings